Capital Advisors Ltd’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Hold
38
﹤0.01% 840
2026
Q1
$10K Hold
38
﹤0.01% 831
2025
Q4
$10K Hold
38
﹤0.01% 814
2025
Q3
$11K Hold
38
﹤0.01% 782
2025
Q2
$10K Sell
38
-2
-5% -$487 ﹤0.01% 793
2025
Q1
$9K Sell
40
-1
-2% -$243 ﹤0.01% 804
2024
Q4
$9K Buy
41
+3
+8% +$688 ﹤0.01% 812
2024
Q3
$8K Hold
38
﹤0.01% 823
2024
Q2
$8K Sell
38
-3
-7% -$610 ﹤0.01% 805
2024
Q1
$9K Buy
41
+3
+8% +$661 ﹤0.01% 742
2023
Q4
$9K Sell
38
-13
-25% -$2.73K ﹤0.01% 713
2023
Q3
$10K Sell
51
-10
-16% -$2.11K ﹤0.01% 686
2023
Q2
$13K Buy
61
+17
+39% +$3.3K ﹤0.01% 645
2023
Q1
$9K Sell
44
-18
-29% -$3.7K ﹤0.01% 576
2022
Q4
$12K Buy
62
+18
+41% +$3.52K ﹤0.01% 535
2022
Q3
$8K Sell
44
-10
-19% -$2.05K ﹤0.01% 572
2022
Q2
$11K Buy
54
+10
+23% +$2.13K ﹤0.01% 497
2022
Q1
$10K Sell
44
-3
-6% -$706 ﹤0.01% 525
2021
Q4
$13K Buy
+47
New +$11.6K ﹤0.01% 486

Other funds holding LH

Capital Advisors Ltd's LH Position: Q2 2026 in Review

Capital Advisors Ltd held its Labcorp (LH) position steady in Q2 2026 at 38 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Capital Advisors Ltd first reported a position in LH in Q4 2021 and has held it in 19 quarters since. The position peaked at $13K in Q2 2023. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Capital Advisors Ltd held 38 shares of Labcorp worth $11K as of Q2 2026.
  • Capital Advisors Ltd left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #840 holding.
  • Capital Advisors Ltd first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
  • Capital Advisors Ltd's Labcorp position peaked at $13K in Q2 2023.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.